Loading...
XSTO
EPISb
Market cap7mUSD
May 28, Last price  
0.11SEK
1D
-1.23%
1Q
1.45%
Jan 2017
-99.02%
IPO
-99.77%
Name

Episurf Medical AB

Chart & Performance

D1W1MN
P/E
—
P/S
5.62
EPS
—
Div Yield, %
—
Shrs. gr., 5y
49.02%
Rev. gr., 5y
21.55%
Revenues
13m
+26.21%
000037,916173,0261,016,4622,405,6142,490,2484,000,0004,900,0005,000,0006,500,0006,600,00010,300,00013,000,000
Net income
-76m
L-19.83%
-540,241-2,786,253-4,458,653-15,769,779-22,856,694-32,914,421-43,974,662-61,667,464-61,093,452-57,800,000-70,600,000-64,600,000-69,500,000-77,300,000-94,800,000-76,000,000
CFO
-71m
L-15.80%
-1,998,651-3,913,785-15,045,172-20,642,962-31,659,426-38,039,032-56,096,044-61,381,599-52,300,000-59,200,000-54,100,000-59,700,000-69,500,000-84,800,000-71,400,000
Earnings
Jul 10, 2025

Profile

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, it offers µiFidelity, an order management system, for placing and following up on order, uploading MRI scans, and consult patient's damage marking report. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
URL
https://episurf.com/
IPO date
Nov 05, 2010
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,000
26.21%
10,300
56.06%
6,600
1.54%
Cost of revenue
14,200
107,100
15,800
Unusual Expense (Income)
NOPBT
(1,200)
(96,800)
(9,200)
NOPBT Margin
Operating Taxes
100
200
100
Tax Rate
NOPAT
(1,300)
(97,000)
(9,300)
Net income
(76,000)
-19.83%
(94,800)
22.64%
(77,300)
11.22%
Dividends
Dividend yield
Proceeds from repurchase of equity
74,000
200
500
BB yield
-109.32%
-0.08%
-0.08%
Debt
Debt current
2,300
2,900
2,500
Long-term debt
2,300
7,500
10,100
Deferred revenue
Other long-term liabilities
100
100
1,000
Net debt
(45,900)
(47,500)
(142,700)
Cash flow
Cash from operating activities
(71,400)
(84,800)
(69,500)
CAPEX
(7,600)
(11,300)
Cash from investing activities
(7,600)
(9,500)
(11,200)
Cash from financing activities
71,600
(3,000)
(1,900)
FCF
1,500
(95,700)
(13,000)
Balance
Cash
50,500
57,900
155,300
Long term investments
Excess cash
49,850
57,385
154,970
Stockholders' equity
(748,700)
(600,000)
(506,900)
Invested Capital
834,900
689,800
691,900
ROIC
ROCE
EV
Common stock shares outstanding
494,825
266,997
266,627
Price
0.14
-86.18%
0.99
-57.87%
2.35
-48.35%
Market cap
67,692
-74.39%
264,327
-57.81%
626,574
-39.23%
EV
21,792
216,827
484,074
EBITDA
7,800
(90,800)
(1,800)
EV/EBITDA
2.79
Interest
1,000
900
700
Interest/NOPBT